Definitive Contract HHSN261200433006C
Award Date 6/30/04
Potential Completion Date 6/29/11
Potential Value $24M
Federal Agency
Ultimate Awardee
NAICS Category
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Chicago, IL 60612, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Cancer Institute, a civilian agency under the U.S. Department of Health and Human Services, to the University of Illinois for a "CONTRACT ORIENTATION AND KICKOFF MEETING" from September 30, 2015 to December 31, 2015. The award, which has a ceiling value of $2,587.19, is a delivery order under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) indefinite delivery/indefinite quantity (IDIQ) contract. The contract has a...
- This federal contract award, valued at $149,395.10, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Illinois, a major public research university system. The contract is for professional and consulting services and does not have a set-aside designation. The University of Illinois has been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract from the National Cancer Institute, valued at $149,995,000, to support the PREVENT Cancer Preclinical...
- This federal contract award is a definitive contract between the University of Illinois, doing business as The Board of Trustees of the University of Illinois, and the U.S. government. The contract has a potential value of $200,000.00 and was awarded on May 15, 2001, with a completion date of December 31, 2006. The contract does not have a set-aside designation. The University of Illinois is a major public research university system that has performed a wide range of research and development...
- This is a federal contract award to the University of Illinois, a major public research university, by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract, valued at $2,062,263.00, is for research and development services related to chemical and radiological/nuclear agent countermeasures. It is a delivery order under the BARDA Chem and RadNuc Animal Model 2015-2020 Indefinite Delivery Indefinite Quantity (IDIQ) contract. This IDIQ contract, valued at...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract, valued at $1,931,792.00, supports the clinical development of an HPV16L1/RG1 chimeric virus-like particle vaccine under the NCI's PRECLINICAL PREVENT TOXICOLOGY AND PHARMACOLOGY major program. The contract has a period of performance from September 25, 2015 to December 31, 2021 and does not have a set-aside designation. The University of Illinois is the...
- This federal contract was awarded by a U.S. government agency to the University of Illinois, doing business as The Board of Trustees of the University of Illinois, a public research university system based in Chicago. The $450,000.00 Firm Fixed Price contract is for the "Evaluation of the Added-Value of Multi-Dimensional and Hierarchical Psychometric Modeling for Cancer Outcomes Measurement." There was no set-aside designation for this contract. The University of Illinois has a long...
- The National Cancer Institute issued a delivery order to the University of Illinois on September 17, 2018, for preclinical toxicology and pharmacology research on a dual AKT/PDPK1 inhibitor for actinic keratosis and skin cancer prevention in immunocompromised individuals, with a ceiling value of $2,273,213.36. The order is issued under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) parent IDIQ. Place of performance is Urbana, IL. The order is firm fixed price with an ultimate...
- This federal contract award to the University of Illinois, doing business as The Board of Trustees of the University of Illinois, was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), a civilian agency. The $633,029.25 cost-no-fee definitive contract is for biomedical research and exploratory work, with a completion date of June 3, 2013. The University of Illinois has extensive experience as both a prime contractor and subcontractor...
- The National Cancer Institute issued a delivery order to the University of Illinois on September 1, 2016, with a ceiling value of $712,043.02, under the Toxicology of Drugs Developed for Cancer Patients IDIQ to conduct preclinical toxicology studies of a DNA methyltransferase inhibitor (TDCYD) in support of cancer drug development. The order encompasses two study components: a rat study valued at $234,760 and a dog study valued at $478,298. Place of performance is Chicago, IL. Work is to be...
- This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...